Tumor Vaccine Group 2008 Open House

November 30, 2013

Dr. Mary L. “Nora” Disis, professor of medicine at the University of Washington, joins Dr. Kathleen Tietje, administrative director at the Tumor Vaccine Group, to discuss the group and its mission of being a multidisciplinary group of investigators focused on the diagnosis, prevention and treatment of cancer with novel, immune-based therapies. Involving scientists, doctors, nurses, and patients, our translational research works to bring the most innovative treatments from the bench to the bedside and to harmonize scientific study with patient care.

Dr. Mary L. “Nora” Disis, director & founder, Tumor Vaccine Group; professor, Dept of Med, Div Oncology, University of Washington
Dr. Kathleen Tietje, administrative director, Tumor Vaccine Group